Dhananjay Jere

Dhananjay Jere is an experienced professional in the biopharmaceutical industry, currently serving as Head of Drug Product Development and Director at Fresenius Kabi since August 2021, where responsibilities include overseeing biopharma product and process development, validations, and manufacturing activities, along with managing MSAT and technology transfer processes. Prior experience includes serving as a Scientific Ambassador at Lonza from September 2016 to August 2021, focusing on business planning for portfolio diversification, and as Group Leader and Principal Scientist at Roche from March 2010 to August 2016, primarily in biopharmaceutical development and regulatory submissions. Early career experience includes a research trainee position at Colgate Palmolive, specializing in oral care formulation development. Dhananjay Jere holds an Executive MBA from the University of St. Gallen, a PhD in Pharmaceutics from Seoul National University, a Master's in Pharmaceutics from Bombay College of Pharmacy, and a Bachelor's in Pharmaceutical Sciences from Poona College of Pharmacy.